PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $310,000 | -42.6% | 101,947 | +65.2% | 0.00% | -75.0% |
| Q4 2019 | $540,000 | +241.8% | 61,711 | +320.4% | 0.00% | +300.0% |
| Q3 2019 | $158,000 | -72.4% | 14,678 | -67.5% | 0.00% | -80.0% |
| Q2 2019 | $573,000 | +59.2% | 45,100 | +384.9% | 0.01% | +150.0% |
| Q1 2019 | $360,000 | +16.5% | 9,300 | -38.8% | 0.00% | 0.0% |
| Q4 2018 | $309,000 | -20.6% | 15,199 | +79.1% | 0.00% | +100.0% |
| Q3 2018 | $389,000 | +872.5% | 8,486 | +1314.3% | 0.00% | – |
| Q3 2016 | $40,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |